While nuclear medicine continues to be an important diagnostic technique for many conditions, rapid technological developments and shared expertise between radiologists and clinicians give it an increasingly important and much wider role, particularly in treatment. This changing scene is reflected in the contents of this fully updated third edition of 'Clinical Nuclear Medicine', written by a team of experienced international contributors from the UK, USA, Canada, South Africa, Netherlands, Belgium and Italy.
New material includes SPECT, image registration, new tracer approaches (radiopeptides and radio-oligonucleotides) and new radiopharmaceuticals (including untoward reactions to them), genital conditions and psychiatric disorders, dementia and epilepsy, HIV, autoimmune disease and immunosuppression and discussion of patient concerns (explanations, ethical issues, staff and public relations).
New material includes SPECT, image registration, new tracer approaches (radiopeptides and radio-oligonucleotides) and new radiopharmaceuticals (including untoward reactions to them), genital conditions and psychiatric disorders, dementia and epilepsy, HIV, autoimmune disease and immunosuppression and discussion of patient concerns (explanations, ethical issues, staff and public relations).